Washington State University dedicated the $61.9 million Washington Animal Disease Diagnostic Laboratory in May of 2021.
The International Society for Pharmaceutical Engineering has announced the 2021 Facility of the Year Awards category winners. The awards include:
Vibalogics is creating a 110,000-sf facility for the production of oncolytic viruses, viral vector vaccines, and viral vector gene therapy products in Boxborough, Mass.
Texas Biomedical Research Institute is planning to construct the $10 million Nonhuman Primate Animal Facility in San Antonio.
California Institute of Technology dedicated the $210 million Tianqiao and Chrissy Chen Neuroscience Research Building in January of 2021 in Pasadena.
The Massachusetts Center for Advanced Biological Innovation and Manufacturing is planning to create a 40,000-sf facility in Watertown, Mass.
The needs and architectural considerations for a veterinary diagnostic laboratory (VDL) have evolved toward a greater focus on the value of human-centered design. At its core, the VDL’s purpose to provide diagnostic testing for infectious animal diseases remains the same: Biosafety and biosecurity are a top priority, while designs have evolved to meet today’s demands and anticipated future technological advancements. However, the visionary and technological advancements of recent decades have also resulted in an increased focus on designing with efficiency and quality of workplace in mind.
Thermo Fisher Scientific is expanding its global production capacity for vaccines, medicines, and biologic therapies.
Nationwide Children's Hospital is constructing a $100 million gene therapy manufacturing center in Columbus, Ohio.